bioRxiv Science⌕ Search

Biology subjects

Normandin, C.

Publications and source records attributed to Normandin, C..

2 recordsLinked to original sources

A Drosophila eye modifier screen identifies TBC1D25 as a modulator of RAB21 phenotypes

Membrane trafficking is essential to maintain cellular homeostasis, enabling cells and organelles to exchange molecular components via vesicle transport. Therefore, it is tightly regulated, including by RAB GTPases. Among these, RAB21, which is primarily associated with early endosomes, plays a central role in coordinating endocytosis, sorting, and degradation. Like other RABs, it cycles between GTP- and GDP-bound forms. Although three specific guanine exchange factors (GEFs) for RAB21 have been identified, surprisingly, no GTPase-activating proteins (GAPs) have been found to directly modulate RAB21. Here, we describe a genetic modifier screen in Drosophila that identified Tre/Bub2/Cdc16 (TBC) domain family member 25 (TBC1D25) as a potential negative regulator of RAB21. We confirmed the RAB21-TBC1D25 interaction using co-immunoprecipitation and proximity ligation assays and further demonstrated that their association depends on the catalytic activity of TBC1D25. Genetic interaction studies revealed a functional link between TBC1D25 and RAB21 in autophagy and cargo sorting. Collectively, our results indicate that TBC1D25 negatively regulates RAB21, potentially by serving as a RAB21-specific GAP.

cell biology↗

In vitro and in vivo activity profiles of broad-spectrum bacterial ATP synthase inhibitors

Tomatidine (TO), a natural steroidal alkaloid derived from Solanaceae (e.g., tomato), is recognized for its narrow-spectrum antibiotic activity, particularly against persistent forms of Staphylococcus aureus, such as small-colony variants (SCVs). Previous studies have shown that TO exerts its effect by inhibiting S. aureus ATP synthase. In earlier work, we synthesized nearly 100 TO analogs featuring an ethylenediamine linker branched with aromatic substituents at the C3 position, and demonstrated that several of these analogs possess notable antibacterial activity against typical (non-SCV) S. aureus strains, including methicillin-resistant S. aureus (MRSA), with minimum inhibitory concentrations (MICs) ranging from 1 to 4 {micro}g/mL. Among these, analogs incorporating an indole (TM-247) or para-substituted aryl moiety (TM-184, -I; TM-218, -Cl; TM-220, -Br; TM-303, -CF) emerged as lead candidates, exhibiting potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including S. aureus SCVs. In the present study, we conducted a comprehensive antibacterial profiling of this compound series, including the predecessor compound TM-02, against a panel comprising 16 Gram-positive strains, 16 antibiotic-resistant Escherichia coli isolates, and two multidrug-resistant Acinetobacter baumannii strains. TM-184 emerged as the most promising candidate and was subsequently subjected to an expanded in vitro evaluation across 24 clinically relevant Gram-negative bacterial species. Furthermore, TM-184 was assessed in vivo using a neutropenic mouse thigh infection model against E. coli, where it demonstrated significant efficacy, leading to a substantial reduction in bacterial burden.

molecular biology↗